Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain
Completed · Not applicable
Conditions studied: Spinal Cord Injuries, Neuropathic Pain
In brief
A prospective case control study to determine the effectiveness and longevity of 8% capsaicin patch(es) in treating neuropathic pain in persons with spinal cord injury. The investigators will study spinal cord injury patients at South Texas Veterans Health Care Systems Spinal Cord Injury inpatient unit and outpatient clinics.
Key facts
- Study ID
- NCT02441660
- Run by
- The University of Texas Health Science Center at San Antonio
- People needed
- 11
- Starts
- 2016-04-01
- Expected to finish
- 2022-05-02
- Last updated by the study team
- 2023-01-26
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Diagnosis of SCI
- Neuropathic pain below level of injury
- Surface area of pain no larger than 2 patches
- Failed or did not tolerate gabapentin 3600mg/day, pregabalin 600mg/day, capsaicin cream and/or lidocaine cream
- Skin over painful area intact
You may not qualify if…
- Pain over open wound
- Previously documented allergy to capsaicin
- Superficial burn over area of pain
- Premorbid (before SCI) neuropathic pain
- HIV/AIDS neuropathy
Where it is running
- Audie Lee Murphy VA Hospital — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.